Matthew Lunning
7PUBLICATIONS
77CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 29, 2025
Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.Jason Yongsheng Chan, Ayumi Fujimoto, Gin Gin Gan
|Oct 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.Jason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang
|Apr 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects.Alexandria P Eiken, Audrey L Smith, Sydney A Skupa
|Mar 20, 2024
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu
|Mar 14, 2024
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System.Magdi Elsallab, Moataz Ellithi, Matthew A Lunning
|Jan 22, 2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.Jennifer L Crombie, Tara Graff, Lorenzo Falchi
Pageof 2
Frequent Collaborators
2 joint publications
Ayumi Fujimoto
2 joint publications
Won Seog Kim
2 joint publications
Kian Meng Chang
2 joint publications
Gin Gin Gan
2 joint publications
Do Huyen Nga
2 joint publications
Brad S Kahl
2 joint publications
Jason Yongsheng Chan
2 joint publications
Jay Datukan
2 joint publications
Soo Chin Ng
2 joint publications
Christopher R D'Angelo
